Entertainment
Compare Stocks
5 / 10Stock Comparison
CNVS vs CURI vs FUBO vs AMCX vs PHUN
Revenue, margins, valuation, and 5-year total return — side by side.
Broadcasting
Broadcasting
Entertainment
Software - Application
CNVS vs CURI vs FUBO vs AMCX vs PHUN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Entertainment | Broadcasting | Broadcasting | Entertainment | Software - Application |
| Market Cap | $51M | $184M | $317M | $98M | $41M |
| Revenue (TTM) | $55M | $72M | $2.72B | $2.32B | $2M |
| Net Income (TTM) | $-9M | $-6M | $156M | $-140M | $-12M |
| Gross Margin | 53.9% | 56.6% | 11.1% | 51.0% | 41.3% |
| Operating Margin | -12.5% | -10.2% | -2.6% | -3.0% | -7.4% |
| Forward P/E | 16.4x | 89.7x | — | 5.0x | — |
| Total Debt | $462K | $12M | $670M | $0.00 | $932K |
| Cash & Equiv. | $14M | $18M | $452M | — | $113M |
CNVS vs CURI vs FUBO vs AMCX vs PHUN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cineverse Corp. (CNVS) | 100 | 15.5 | -84.5% |
| CuriosityStream Inc. (CURI) | 100 | 32.1 | -67.9% |
| fuboTV Inc. (FUBO) | 100 | 7.8 | -92.2% |
| AMC Networks Inc. (AMCX) | 100 | 30.3 | -69.7% |
| Phunware, Inc. (PHUN) | 100 | 3.1 | -96.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CNVS vs CURI vs FUBO vs AMCX vs PHUN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CNVS lags the leaders in this set but could rank higher in a more targeted comparison.
CURI ranks third and is worth considering specifically for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 1.44, yield 12.2%
- -63.2% 10Y total return vs AMCX's -87.4%
- Lower volatility, beta 1.44, Low D/E 30.0%, current ratio 1.23x
- Beta 1.44, yield 12.2%, current ratio 1.23x
FUBO carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 67.7%, EPS growth 96.3%, 3Y rev CAGR 39.2%
- 67.7% revenue growth vs PHUN's -34.0%
- 5.7% margin vs PHUN's -5.1%
- 8.1% ROA vs CNVS's -13.4%, ROIC -3.3% vs 20.3%
AMCX is the #2 pick in this set and the best alternative if value and stability is your priority.
- Better valuation composite
- Beta 0.86 vs PHUN's 2.37
- +29.1% vs FUBO's -65.6%
Among these 5 stocks, PHUN doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 67.7% revenue growth vs PHUN's -34.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 5.7% margin vs PHUN's -5.1% | |
| Stability / Safety | Beta 0.86 vs PHUN's 2.37 | |
| Dividends | 12.2% yield; 2-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +29.1% vs FUBO's -65.6% | |
| Efficiency (ROA) | 8.1% ROA vs CNVS's -13.4%, ROIC -3.3% vs 20.3% |
CNVS vs CURI vs FUBO vs AMCX vs PHUN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CNVS vs CURI vs FUBO vs AMCX vs PHUN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMCX leads in 2 of 6 categories
CURI leads 2 • FUBO leads 1 • CNVS leads 0 • PHUN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
FUBO leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
FUBO is the larger business by revenue, generating $2.7B annually — 1154.9x PHUN's $2M. FUBO is the more profitable business, keeping 5.7% of every revenue dollar as net income compared to PHUN's -5.1%. On growth, FUBO holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $55M | $72M | $2.7B | $2.3B | $2M |
| EBITDAEarnings before interest/tax | -$2M | $14M | -$14M | $686M | -$17M |
| Net IncomeAfter-tax profit | -$9M | -$6M | $156M | -$140M | -$12M |
| Free Cash FlowCash after capex | -$13M | $13M | -$81M | $267M | -$12M |
| Gross MarginGross profit ÷ Revenue | +53.9% | +56.6% | +11.1% | +51.0% | +41.3% |
| Operating MarginEBIT ÷ Revenue | -12.5% | -10.2% | -2.6% | -3.0% | -7.4% |
| Net MarginNet income ÷ Revenue | -16.7% | -9.0% | +5.7% | -6.0% | -5.1% |
| FCF MarginFCF ÷ Revenue | -22.8% | +18.1% | -3.0% | +11.5% | -5.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -60.0% | +35.8% | +2.5% | -6.3% | -6.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -113.2% | -31.2% | +81.8% | -10.4% | +52.0% |
Valuation Metrics
AMCX leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, AMCX's 0.1x EV/EBITDA is more attractive than CURI's 24.2x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $51M | $184M | $317M | $98M | $41M |
| Enterprise ValueMkt cap + debt − cash | $38M | $179M | $534M | $98M | -$71M |
| Trailing P/EPrice ÷ TTM EPS | 16.44x | -28.55x | -44.88x | — | -2.15x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 89.71x | — | 5.04x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 3.24x | 24.22x | — | 0.08x | — |
| Price / SalesMarket cap ÷ Revenue | 0.66x | 2.57x | 0.12x | 0.04x | 12.79x |
| Price / BookPrice ÷ Book value/share | 1.24x | 4.36x | 0.12x | — | 0.21x |
| Price / FCFMarket cap ÷ FCF | 3.17x | 14.24x | — | 0.32x | — |
Profitability & Efficiency
Evenly matched — CNVS and FUBO each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
FUBO delivers a 16.2% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-24 for CNVS. PHUN carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to CURI's 0.30x. On the Piotroski fundamental quality scale (0–9), CNVS scores 7/9 vs AMCX's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -24.4% | -13.1% | +16.2% | -12.2% | -11.6% |
| ROA (TTM)Return on assets | -13.4% | -8.2% | +8.1% | -3.3% | -10.8% |
| ROICReturn on invested capital | +20.3% | -12.2% | -3.3% | +12.1% | — |
| ROCEReturn on capital employed | +22.3% | -13.6% | -4.1% | — | -28.2% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 4 | 3 | 4 |
| Debt / EquityFinancial leverage | 0.01x | 0.30x | 0.25x | — | 0.01x |
| Net DebtTotal debt minus cash | -$13M | -$6M | $218M | $0 | -$112M |
| Cash & Equiv.Liquid assets | $14M | $18M | $452M | — | $113M |
| Total DebtShort + long-term debt | $462,000 | $12M | $670M | $0 | $932,000 |
| Interest CoverageEBIT ÷ Interest expense | -4.16x | — | 10.35x | 0.95x | -196.80x |
Total Returns (Dividends Reinvested)
CURI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CURI five years ago would be worth $2,978 today (with dividends reinvested), compared to $299 for PHUN. Over the past 12 months, AMCX leads with a +29.1% total return vs FUBO's -65.6%. The 3-year compound annual growth rate (CAGR) favors CURI at 54.7% vs PHUN's -59.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +25.2% | -14.4% | -65.3% | -7.5% | +9.2% |
| 1-Year ReturnPast 12 months | -5.1% | -23.1% | -65.6% | +29.1% | -29.4% |
| 3-Year ReturnCumulative with dividends | -60.2% | +270.5% | -51.7% | -44.0% | -93.4% |
| 5-Year ReturnCumulative with dividends | -89.3% | -70.2% | -94.8% | -81.9% | -97.0% |
| 10-Year ReturnCumulative with dividends | -93.4% | -63.2% | -90.3% | -87.4% | -99.6% |
| CAGR (3Y)Annualised 3-year return | -26.4% | +54.7% | -21.6% | -17.6% | -59.5% |
Risk & Volatility
AMCX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
AMCX is the less volatile stock with a 0.86 beta — it tends to amplify market swings less than PHUN's 2.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMCX currently trades 84.1% from its 52-week high vs FUBO's 19.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.44x | 1.44x | 1.77x | 0.86x | 2.37x |
| 52-Week HighHighest price in past year | $7.39 | $7.15 | $56.64 | $10.18 | $3.88 |
| 52-Week LowLowest price in past year | $1.77 | $2.81 | $2.48 | $5.41 | $1.56 |
| % of 52W HighCurrent price vs 52-week peak | +35.6% | +43.9% | +19.0% | +84.1% | +52.1% |
| RSI (14)Momentum oscillator 0–100 | 60.7 | 43.0 | 38.0 | 57.3 | 45.6 |
| Avg Volume (50D)Average daily shares traded | 145K | 349K | 1.9M | 386K | 140K |
Analyst Outlook
CURI leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: CURI as "Buy", FUBO as "Hold", AMCX as "Hold". Consensus price targets imply 299.3% upside for FUBO (target: $43) vs -6.5% for AMCX (target: $8). CURI is the only dividend payer here at 12.16% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Hold | — |
| Price TargetConsensus 12-month target | — | $3.67 | $43.00 | $8.00 | — |
| # AnalystsCovering analysts | — | 9 | 14 | 40 | — |
| Dividend YieldAnnual dividend ÷ price | — | +12.2% | — | — | — |
| Dividend StreakConsecutive years of raises | — | 2 | — | 0 | — |
| Dividend / ShareAnnual DPS | — | $0.38 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | 0.0% | 0.0% | 0.0% | 0.0% |
AMCX leads in 2 of 6 categories (Valuation Metrics, Risk & Volatility). CURI leads in 2 (Total Returns, Analyst Outlook). 1 tied.
CNVS vs CURI vs FUBO vs AMCX vs PHUN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CNVS or CURI or FUBO or AMCX or PHUN a better buy right now?
For growth investors, fuboTV Inc.
(FUBO) is the stronger pick with 67. 7% revenue growth year-over-year, versus -34. 0% for Phunware, Inc. (PHUN). Cineverse Corp. (CNVS) offers the better valuation at 16. 4x trailing P/E, making it the more compelling value choice. Analysts rate CuriosityStream Inc. (CURI) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CNVS or CURI or FUBO or AMCX or PHUN?
On forward P/E, AMC Networks Inc.
is actually cheaper at 5. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CNVS or CURI or FUBO or AMCX or PHUN?
Over the past 5 years, CuriosityStream Inc.
(CURI) delivered a total return of -70. 2%, compared to -97. 0% for Phunware, Inc. (PHUN). Over 10 years, the gap is even starker: CURI returned -63. 2% versus PHUN's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CNVS or CURI or FUBO or AMCX or PHUN?
By beta (market sensitivity over 5 years), AMC Networks Inc.
(AMCX) is the lower-risk stock at 0. 86β versus Phunware, Inc. 's 2. 37β — meaning PHUN is approximately 177% more volatile than AMCX relative to the S&P 500. On balance sheet safety, Phunware, Inc. (PHUN) carries a lower debt/equity ratio of 1% versus 30% for CuriosityStream Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CNVS or CURI or FUBO or AMCX or PHUN?
By revenue growth (latest reported year), fuboTV Inc.
(FUBO) is pulling ahead at 67. 7% versus -34. 0% for Phunware, Inc. (PHUN). On earnings-per-share growth, the picture is similar: Cineverse Corp. grew EPS 109. 0% year-over-year, compared to 54. 2% for CuriosityStream Inc.. Over a 3-year CAGR, FUBO leads at 39. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CNVS or CURI or FUBO or AMCX or PHUN?
AMC Networks Inc.
(AMCX) is the more profitable company, earning 8. 4% net margin versus -323. 5% for Phunware, Inc. — meaning it keeps 8. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CNVS leads at 10. 1% versus -435. 5% for PHUN. At the gross margin level — before operating expenses — CURI leads at 56. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CNVS or CURI or FUBO or AMCX or PHUN more undervalued right now?
On forward earnings alone, AMC Networks Inc.
(AMCX) trades at 5. 0x forward P/E versus 89. 7x for CuriosityStream Inc. — 84. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FUBO: 299. 3% to $43. 00.
08Which pays a better dividend — CNVS or CURI or FUBO or AMCX or PHUN?
In this comparison, CURI (12.
2% yield) pays a dividend. CNVS, FUBO, AMCX, PHUN do not pay a meaningful dividend and should not be held primarily for income.
09Is CNVS or CURI or FUBO or AMCX or PHUN better for a retirement portfolio?
For long-horizon retirement investors, AMC Networks Inc.
(AMCX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 86)). Phunware, Inc. (PHUN) carries a higher beta of 2. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AMCX: -87. 4%, PHUN: -99. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CNVS and CURI and FUBO and AMCX and PHUN?
These companies operate in different sectors (CNVS (Communication Services) and CURI (Communication Services) and FUBO (Communication Services) and AMCX (Communication Services) and PHUN (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CNVS is a small-cap high-growth stock; CURI is a small-cap high-growth stock; FUBO is a small-cap high-growth stock; AMCX is a small-cap quality compounder stock; PHUN is a small-cap quality compounder stock. CURI pays a dividend while CNVS, FUBO, AMCX, PHUN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 17%
- Gross Margin > 33%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.